Ruoyu Ling
1838 North Guangzhou Avenue
Guangzhou, 510515, China
Guangzhou, 510515, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
ELFN2 inhibits YAP-driven lymph node metastasis in gastric cancer by blocking PP1A-mediated dephosphorylation.
Journal: Experimental cell research
Published: December 12, 2025
Targeting the NAT10/XIST/YAP1 Axis-Mediated Vascular Abnormalization Enhances Immune Checkpoint Blockade in Gastric Cancer.
Journal: International journal of biological sciences
Published: March 06, 2025
Modulating hypertrophic scar formation by targeting endothelial transient receptor potential vanilloid-1/nuclear factor kappa-B/interleukin-6 axis to regulate angiogenesis.
Journal: Burns & trauma
Published: February 12, 2025
CD44v6-mediated regulation of gastric cancer stem cells: a potential therapeutic target.
Journal: Clinical and experimental medicine
Published: January 21, 2025
UBAP2L-driven stress granule formation links oxaliplatin resistance to gastric cancer.
Journal: Communications biology
Published: January 14, 2025
Helicobacter pylori CagA-mediated ether lipid biosynthesis promotes ferroptosis susceptibility in gastric cancer.
Journal: Experimental & molecular medicine
Published: July 28, 2023
N4-Acetylcytidine Drives Glycolysis Addiction in Gastric Cancer via NAT10/SEPT9/HIF-1α Positive Feedback Loop.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: February 09, 2023
Fibroblast-derived LPP as a biomarker for treatment response and therapeutic target in gastric cancer.
Journal: Molecular therapy oncolytics
Published: July 08, 2021
Nuclear MYH9-induced CTNNB1 transcription, targeted by staurosporin, promotes gastric cancer cell anoikis resistance and metastasis.
Journal: Theranostics
Published: March 14, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026